These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 34205996)
81. Dehydroepiandrosterone activates 5'-adenosine monophosphate-activated protein kinase and suppresses lipid accumulation and adipocyte differentiation in 3T3-L1 cells. Yokokawa T; Sato K; Narusawa R; Kido K; Mori R; Iwanaka N; Hayashi T; Hashimoto T Biochem Biophys Res Commun; 2020 Jul; 528(3):612-619. PubMed ID: 32505344 [TBL] [Abstract][Full Text] [Related]
82. Disentangling the signaling pathways of mTOR complexes, mTORC1 and mTORC2, as a therapeutic target in glioblastoma. Jhanwar-Uniyal M; Dominguez JF; Mohan AL; Tobias ME; Gandhi CD Adv Biol Regul; 2022 Jan; 83():100854. PubMed ID: 34996736 [TBL] [Abstract][Full Text] [Related]
83. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship. Jhanwar-Uniyal M; Wainwright JV; Mohan AL; Tobias ME; Murali R; Gandhi CD; Schmidt MH Adv Biol Regul; 2019 May; 72():51-62. PubMed ID: 31010692 [TBL] [Abstract][Full Text] [Related]
84. Semi-synthetic product dihydroartemisinin inhibited fibronectin-1 and integrin-β1 and interfered with the migration of HCCLM6 cells via PI3K-AKT pathway. Wu R; Gao Y; Wu J; Wang C; Yang L Biotechnol Lett; 2020 Jun; 42(6):917-926. PubMed ID: 32072334 [TBL] [Abstract][Full Text] [Related]
85. Combined mTORC1/mTORC2 inhibition blocks growth and induces catastrophic macropinocytosis in cancer cells. Srivastava RK; Li C; Khan J; Banerjee NS; Chow LT; Athar M Proc Natl Acad Sci U S A; 2019 Dec; 116(49):24583-24592. PubMed ID: 31732667 [TBL] [Abstract][Full Text] [Related]
86. ABHD5 suppresses cancer cell anabolism through lipolysis-dependent activation of the AMPK/mTORC1 pathway. Chen G; Zhou G; Lotvola A; Granneman JG; Wang J J Biol Chem; 2021; 296():100104. PubMed ID: 33219129 [TBL] [Abstract][Full Text] [Related]
87. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways. Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725 [TBL] [Abstract][Full Text] [Related]
88. The association of AMPK with ULK1 regulates autophagy. Lee JW; Park S; Takahashi Y; Wang HG PLoS One; 2010 Nov; 5(11):e15394. PubMed ID: 21072212 [TBL] [Abstract][Full Text] [Related]
89. Activation of AMPK/TSC2/PLD by alcohol regulates mTORC1 and mTORC2 assembly in C2C12 myocytes. Hong-Brown LQ; Brown CR; Navaratnarajah M; Lang CH Alcohol Clin Exp Res; 2013 Nov; 37(11):1849-61. PubMed ID: 23895284 [TBL] [Abstract][Full Text] [Related]
97. Baicalin Induced Apoptosis of Human Cholangiocarcinoma Cell through Activating AMPK/mTORC1/p70S6K Signaling Pathway. Jia M; Yang F; Xu Y; Xu Q; Zeng Y; Dai R; Xiang Y Bull Exp Biol Med; 2022 Jul; 173(3):366-370. PubMed ID: 35854022 [TBL] [Abstract][Full Text] [Related]
98. The ability to utilise ammonia as nitrogen source is cell type specific and intricately linked to GDH, AMPK and mTORC1. Lie S; Wang T; Forbes B; Proud CG; Petersen J Sci Rep; 2019 Feb; 9(1):1461. PubMed ID: 30728400 [TBL] [Abstract][Full Text] [Related]
99. Folliculin Interacting Protein 1 Maintains Metabolic Homeostasis during B Cell Development by Modulating AMPK, mTORC1, and TFE3. Ramírez JA; Iwata T; Park H; Tsang M; Kang J; Cui K; Kwong W; James RG; Baba M; Schmidt LS; Iritani BM J Immunol; 2019 Dec; 203(11):2899-2908. PubMed ID: 31676673 [TBL] [Abstract][Full Text] [Related]
100. Inhibition of mTORC1 by SU6656, the selective Src kinase inhibitor, is not accompanied by activation of Akt/PKB signalling in melanoma cells. Ondrušová L; Réda J; Záková P; Tuháčková Z Folia Biol (Praha); 2013; 59(4):162-7. PubMed ID: 24093774 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]